AbbVie to Host Third-Quarter 2024 Earnings Conference Call
AbbVie to Host Third-Quarter 2024 Earnings Conference Call
NORTH CHICAGO, Ill., Oct. 1, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2024 financial results on Wednesday, October 30, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
2024年10月1日，伊利諾伊州北芝加哥/美通社報道--艾伯維公司（NYSE: ABBV）將於2024年10月30日星期三市場開盤前公佈其2024年第三季度財務業績。艾伯維公司將於中部時間上午8點舉行現場網絡直播的業績會。可以通過艾伯維公司的投資者關係網站investors.abbvie.com進行訪問。當天稍後將提供會議的存檔版本。
About AbbVie
關於艾伯維公司
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at . Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
AbbVie的使命是發現和提供創新藥物和解決方案，解決當今嚴重的健康問題並應對未來的醫療挑戰。我們致力於在多個關鍵治療領域 - 免疫治療，腫瘤學，神經科學和眼科領域以及Allergan Aesthetics產品和服務方面產生顯着影響。有關AbbVie的更多信息，請訪問我們的網站。關注LinkedIn，Facebook，Instagram，X (formerly Twitter)和YouTube上的@abbvie。
SOURCE AbbVie
消息來源 艾伯維
譯文內容由第三人軟體翻譯。
